Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / NeuroSense Therapeutics
Entity

NeuroSense Therapeutics

Tracked across 2 events · 12 articles · First seen Jun 02, 2026 · Last active Jul 01, 2026

Sentiment
75
Attention
6
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 80
Tech
Waterloo develops NeuroSense for brain-injury
Impact: NeuroSense Therapeutics is the newly developed monitoring system designed to detect infections in brain-injury cases, offering significant improvements in patient care and potentially reducing healthcare costs. Its successful development and validation position it for future commercialization.
Jun 02, 2026 · 6 articles
6 70
Tech
NeuroDex ExoSORT ALS Biomarker Breakthrough
Impact: NeuroSense Therapeutics conducted the PARADIGM clinical trial where NeuroDex's ExoSORT workflow was applied, demonstrating the effectiveness of its drug candidate PrimeC in reducing NDE-associated TDP-43.
Jul 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track NeuroSense Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.